Article Details

Asia Green Biotechnology Corp. to Fund Initial Human Clinical Trials for Treatment of Migraine ...

Retrieved on: 2021-08-10 12:56:15

Tags for this article:

Click the tags to see associated articles and topics

Asia Green Biotechnology Corp. to Fund Initial Human Clinical Trials for Treatment of Migraine .... View article details on hiswai:

Excerpt

... development and ultimate commercialization the Cannabis sativa varieties to which Pathway and Swysh own the rights for prevention and treatment ...

Article found on: investingnews.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up